Defining Demographic-specific Coronary Artery Calcium Percentiles in the Population Aged ≥75: The ARIC Study and MESA
- PMID: 37655462
- PMCID: PMC10721116
- DOI: 10.1161/CIRCIMAGING.122.015145
Defining Demographic-specific Coronary Artery Calcium Percentiles in the Population Aged ≥75: The ARIC Study and MESA
Abstract
Background: Current clinical guidelines recommend a coronary artery calcium (CAC) score of 100 Agatston Units or demographic-specific 75th percentile as high-risk thresholds for guiding atherosclerotic cardiovascular disease preventive therapy. Meanwhile, low CAC can help derisk individuals who may safely defer statin therapy. However, limited data from the early 2000s, including just 208 older Black individuals, inform CAC percentiles for adults aged 75 to 85 years, and none have been established in adults aged ≥85 years. This study aims to characterize the distribution of CAC and establish demographic-specific CAC percentiles in the population aged ≥75 years.
Methods: We assessed 2886 participants aged ≥75 years without clinical coronary heart disease from the ARIC study (Atherosclerosis Risk in Communities) visit 7 (2018-2019; n=2217) and the MESA (Multi-Ethnic Study of Atherosclerosis) visit 5 (2010-2011; n=669). Prevalence of any CAC >0 and sex- and race-specific CAC percentiles across age were estimated nonparametrically with locally weighted regression models and pooled residual ranking.
Results: The median age was 80 (interquartile interval, 77-83) years, and 60% were female. The prevalence of zero CAC was lowest in White males (4%), followed by Black males (13%), White females (14%), and highest in Black females (18%). Regardless of sex and race, most participants had CAC>100 (62.5%). CAC scores increased with age, with CAC identified in ≈95% of participants aged ≥90 years across sex-race subgroups. The 75th percentile corresponded to higher CAC scores for Black older adults (n=741), especially females, than currently used thresholds.
Conclusions: In community-dwelling adults aged ≥75 years free of clinical coronary heart disease, the prevalence of zero CAC was 11%, and CAC >100 as a threshold for high ASCVD risk would categorize most of this older population as high risk. Demographic-specific CAC percentiles from this study are a valuable tool for interpreting CAC in the population aged ≥75 years.
Keywords: atherosclerosis; calcium; cardiovascular disease; heart disease; tomography.
Conflict of interest statement
Figures



Comment in
-
Heart of the Matter: Expanding the Applicability of CAC to a More Diverse Population.Circ Cardiovasc Imaging. 2023 Sep;16(9):e015849. doi: 10.1161/CIRCIMAGING.123.015849. Epub 2023 Sep 1. Circ Cardiovasc Imaging. 2023. PMID: 37655504 Free PMC article. No abstract available.
Similar articles
-
Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old.J Am Coll Cardiol. 2022 May 17;79(19):1873-1886. doi: 10.1016/j.jacc.2022.02.051. J Am Coll Cardiol. 2022. PMID: 35550683 Free PMC article.
-
Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis).J Am Coll Cardiol. 2009 Jan 27;53(4):345-52. doi: 10.1016/j.jacc.2008.07.072. J Am Coll Cardiol. 2009. PMID: 19161884 Free PMC article.
-
Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).Eur Heart J. 2018 Jul 1;39(25):2401-2408. doi: 10.1093/eurheartj/ehy217. Eur Heart J. 2018. PMID: 29688297 Free PMC article.
-
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.Prog Cardiovasc Dis. 2022 Sep-Oct;74:19-27. doi: 10.1016/j.pcad.2022.08.003. Epub 2022 Aug 8. Prog Cardiovasc Dis. 2022. PMID: 35952728 Free PMC article. Review.
-
Bridging Prevention and Imaging: The Influence of Statins on CAC and CCTA Findings.Curr Atheroscler Rep. 2025 Apr 8;27(1):50. doi: 10.1007/s11883-025-01287-x. Curr Atheroscler Rep. 2025. PMID: 40198377 Review.
Cited by
-
Heart of the Matter: Expanding the Applicability of CAC to a More Diverse Population.Circ Cardiovasc Imaging. 2023 Sep;16(9):e015849. doi: 10.1161/CIRCIMAGING.123.015849. Epub 2023 Sep 1. Circ Cardiovasc Imaging. 2023. PMID: 37655504 Free PMC article. No abstract available.
-
Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study.JACC Cardiovasc Imaging. 2025 May 23:S1936-878X(25)00179-2. doi: 10.1016/j.jcmg.2025.01.019. Online ahead of print. JACC Cardiovasc Imaging. 2025. PMID: 40471761
-
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27. Circulation. 2025. PMID: 39866113 Review.
-
Association between epicardial and pericadial fat thickness and coronary artery calcification severity in chronic kidney disease patients: A pilot study.ARYA Atheroscler. 2025;21(3):38-48. doi: 10.48305/arya.2025.43184.3005. ARYA Atheroscler. 2025. PMID: 40625818 Free PMC article.
-
Use of CT-derived non-cardiovascular calcification marker for predicting cardiovascular events among diabetic older adults: the multi-ethnic study of atherosclerosis.Eur Radiol. 2025 Aug 9. doi: 10.1007/s00330-025-11778-9. Online ahead of print. Eur Radiol. 2025. PMID: 40782222
References
-
- Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O’Leary DH, Tracy R, Watson K, Wong ND and Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45. - PubMed
-
- Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Gronemeyer D, Seibel R, Kalsch H, Brocker-Preuss M, Mann K, Siegrist J, Jockel KH and Heinz Nixdorf Recall Study Investigative G. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol. 2010;56:1397–406. - PubMed
-
- Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J and Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. - PMC - PubMed
-
- Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32. - PubMed
-
- McClelland RL, Chung H, Detrano R, Post W and Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC095161/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- HHSN268201700002C/HL/NHLBI NIH HHS/United States
- HHSN268201700001I/HL/NHLBI NIH HHS/United States
- HHSN268201700004I/HL/NHLBI NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- HHSN268201700004C/HL/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
- T32 HL007024/HL/NHLBI NIH HHS/United States
- R01 HL136592/HL/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- HHSN268201700005C/HL/NHLBI NIH HHS/United States
- HHSN268201700001C/HL/NHLBI NIH HHS/United States
- HHSN268201700003C/HL/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- HHSN268201700002I/HL/NHLBI NIH HHS/United States
- HHSN268201700005I/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- HHSN268201700003I/HL/NHLBI NIH HHS/United States
- U54 GM115428/GM/NIGMS NIH HHS/United States